AirSculpt Technologies logo

AirSculpt Technologies dividend paidNASDAQ: AIRS

TTMAnnual

Dividend paid (quarterly)

$1.00 K
-$12.00 K-92.31%

30 June 2024

-100%vs 3 years high
29.36%vs. sector
Performance
Most recent-92.3%
1 year+100.0%
3 years-100.0%
5 years-

Add series to chart

(max: 6)
company, ETF, index, featured screener or watchlist
series name

Suggested series

Dividend paid (quarterly) performance

Most recent change
AIRS-92.3%
ESPR0.0%
ORGO-
ZIMV-
AMLX-
MXCT-
TBPH-
1 year change
AIRS+100.0%
ESPR0.0%
ORGO-
ZIMV-
AMLX-
MXCT-
TBPH-
3 years change
AIRS-100.0%
ESPR0.0%
ORGO-
ZIMV-
AMLX-
MXCT-
TBPH-
5 years change
AIRS-
ESPR0.0%
ORGO-
ZIMV-
AMLX-
MXCT-
TBPH-

Dividend paid (quarterly) performance

AIRSESPRORGOZIMVAMLXMXCTTBPH
Most recent-92.3%0.0%-----
1 year+100.0%0.0%-----
3 years-100.0%0.0%-----
5 years-0.0%-----
FAQ

What is AirSculpt Technologies dividend paid (quarterly)?

AirSculpt Technologies dividend paid (quarterly) is $1.00 K

What is AirSculpt Technologies dividend paid (quarterly) compared to its all-time maximum value?

AirSculpt Technologies dividend paid (quarterly) is 0% of its all-time maximum value

What is AirSculpt Technologies dividend paid (quarterly) compared to other companies from its sector (Healthcare)?

AirSculpt Technologies dividend paid (quarterly) is higher than 29.36% of the companies in the same sector (Healthcare)

How has AirSculpt Technologies dividend paid (quarterly) changed over the year?

Over the past year, AirSculpt Technologies dividend paid (quarterly) has increased by 100.0%. During the same period, Esperion Therapeutics has not changed

How has AirSculpt Technologies dividend paid (quarterly) changed over the 3 years?

During the last 3 years, AirSculpt Technologies dividend paid (quarterly) has dropped by 100.0%. Over the same period, Esperion Therapeutics has not changed

How has AirSculpt Technologies dividend paid (quarterly) changed over the 5 years?

For the past 5 years, AirSculpt Technologies dividend paid (quarterly) has not changed. In the same period, Esperion Therapeutics has not changed